The AMKL-Other patients, morphologically and/or immunophenotypically considered AML with megakaryoblastic maturation, included one AML patient with inv(16), one AML patient with NPM1-mutations, six AML patients with myelodysplasia-related changes and two AML patients without further classification. This evidence concerns the gene NPM1 and acute myeloid leukemia.